Clinical Trial Update: Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP) [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating whether reducing blood pressure affects high-sensitivity C-reactive protein (hsCRP) levels in patients with hypertension, spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 4 | Status: COMPLETED